Skip to main content
Top
Published in: Intensive Care Medicine 11/2021

01-11-2021 | Aspergillosis | Correspondence

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Authors: Juergen Prattes, Philipp Koehler, Martin Hoenigl, on behalf of the ECMM-CAPA Study Group

Published in: Intensive Care Medicine | Issue 11/2021

Login to get access

Excerpt

We thank Rouze et al. for the thoughtful remarks [1] on our multinational study on pulmonary aspergillosis (CAPA) associated to coronavirus disease 2019 (COVID-19) [2]. …
Literature
2.
go back to reference Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M, Group E-CS (2021) Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M, Group E-CS (2021) Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med
3.
go back to reference Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomeli P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF (2021) Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses 64:364–371CrossRef Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomeli P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF (2021) Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses 64:364–371CrossRef
4.
go back to reference Fekkar A, Neofytos D, Nguyen MH, Clancy CJ, Kontoyiannis DP, Lamoth F (2021) COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases Fekkar A, Neofytos D, Nguyen MH, Clancy CJ, Kontoyiannis DP, Lamoth F (2021) COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases
5.
go back to reference Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Richardson R, Lagrou K, Hoenigl M (2021) Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients– a multinational observational study by the European Confederation of Medical Mycology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2021.08.014 Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Richardson R, Lagrou K, Hoenigl M (2021) Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients– a multinational observational study by the European Confederation of Medical Mycology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://​doi.​org/​10.​1016/​j.​cmi.​2021.​08.​014
Metadata
Title
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
Authors
Juergen Prattes
Philipp Koehler
Martin Hoenigl
on behalf of the ECMM-CAPA Study Group
Publication date
01-11-2021
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 11/2021
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-021-06510-2

Other articles of this Issue 11/2021

Intensive Care Medicine 11/2021 Go to the issue